Results per Page:
‘I can’t remember the last time I saw someone with bad gut GVHD’: BMT expert reflects on recent lifesaving successes
Fred Hutch bone marrow transplant and GVHD expert Dr. Geoffrey Hill explains how a new approach has changed the BMT landscape, where research is headed next
Honoring years of service at Fred Hutch
Celebrating staff whose decades of service have helped shape our mission
He's one of the longest living bone marrow transplant survivors
In this episode of From Bench to Bedside and Beyond, Chris Lundy recounts how he reacted after being told he had a 10% chance of survival
Dr. Shailender Bhatia receives the Lyn and Daniel Lerner Endowed Chair in Merkel Cell Carcinoma
A family’s generosity will fuel the search for new ways to treat an aggressive skin cancer
Stepping up as a bone marrow donor for a sibling
In this episode of From Bench to Bedside and Beyond, Jenn Vehrs recounts her experience as a 7-year-old
Two lifetimes’ worth of bone marrow transplant breakthroughs
Bone marrow transplant pioneer Dr. Rainer Storb retires and reflects on six decades of science and mentorship
Fred Hutch is one of the only centers in the region offering oral medicine services
Specialized oral care for cancer patients is part of multidisciplinary care
New horizons in infectious disease treatment and prevention in immunocompromised patients
The 5th Symposium on Infectious Disease in the Immunocompromised Host emphasized new opportunities, next generation
Multiple myeloma is treatable, not curable. Is that set to change?
Some experts believe a ‘functional cure’ is already within reach
37 years of nourishing care
Fred Hutch registered dietitian Paula Charuhas Macris reflects on changes and progress in patient care over the years
Donor factors influence success of fecal microbiota transplant
From the Rashidi Group, Pathogen Associated Malignancies Program of the Cancer Consortium and Clinical Research Division
Mutations remain one-in-a-million after HCT
From the Storb Group, Clinical Research Division
With Fred Hutch from the very start
Longtime supporters David and Deborah Lycette are more optimistic than ever that research will vanquish cancer
A charming model: new tool evaluates risk of transplant for older patients
Seven values are evaluated to predict outcomes
Infectious disease experts propose trials network dedicated to immunocompromised patients
ImmunOptimize workshop convened stakeholders across disciplines to brainstorm infectious disease clinical trials network designed to serve people with weakened immune systems